HER2 (4B5) breast cancer algorithm by navify® Digital Pathology
Use left and right arrow keys to scroll between the tabs
Whole slide image analysis algorithms
An intelligent and advanced digital pathology solution requires artificial intelligence-based image analysis tools that empower pathologists to confidently and objectively assess whole tissue slide images.
The HER2 (4B5) breast cancer algorithm by navify Digital Pathology* is an adjunctive computer-assisted tool that identifies HER2 positive tumor cell membrane within a pathologist-annotated viable tumor region in images of formalin-fixed, paraffin-embedded neoplastic breast tissue.
Elevate performance, alleviate laboratory demands
Integrated and ready-to-use1
Validated for use with the Roche HER2 (4B5) clone and navify Digital Pathology.
Quick and automated1
Pathologist-trained image analysis algorithm quickly calculates HER2 score.
Accurate, consistent and confident1
Actionable assessment of slide images that are objective and reproducible.1
Explore the benefits of the HER2 (4B5) breast cancer algorithm by navify Digital Pathology*
HER2 (4B5), breast carcinoma algorithm by navify Digital Pathology features:
- Pathologist-trained deep learning algorithm: Objective and reproducible scoring of slides stained with PATHWAY HER2 (4B5) Assay scanned on a VENTANA® DP 200 or DP 600 slide scanner
- Embedded experience: Seamlessly integrated with navify Digital Pathology
- Whole slide analysis (WSA): Automated pre-computing of the slide image prior to pathologist assessment, providing fast results for user-defined regions of interest (ROI)
- Quick automated scoring: Quickly calculates HER2 status across all bins, including 0, 1+, 2+, and 3+, across all levels of HER2 expression
- Clear visual overlay: Highlighting the presence of 1+, 2+, 3+ staining patterns and positive tumor cells at any intensity
Specifications
| Scanner | VENTANA DP 200 and VENTANA DP 600 slide scanners |
| Software | navify Digital Pathology |
| Algorithm | HER2 (4B5) breast cancer algorithm by navify Digital Pathology* |
| Assay | PATHWAY® anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody |
| Tissue Type | Breast |
| Scoring | HER2 Score (0-3+) |
| Regulatory status | Research Use Only (RUO) |
Maximize the potential of your digital pathology laboratory
The Roche Digital Pathology solution comprises high-performance hardware, software and uPath whole slide image analysis algorithms, and works in integrated harmony with the full Roche diagnostic portfolio for an end-to-end experience that enhances pathology workflows.
You might be interested in
*For research use only. Not for use in diagnostic procedures.
Roche Digital Pathology Dx, including navify Digital Pathology, is intended for specific clinical applications and is for research and educational use for other applications. Please review the product labeling for compliance before utilization.
NAVIFY and VENTANA and UPATH are trademarks of Roche. Other product names and trademarks are the property of their respective owners.
Reference:
- Data on file.
